Good Remedies Maximum Strength Urinary Pain Relief Caplet Tablet, Film Coated
NDC Package 70692-178-08
Package Information
Good Remedies Maximum Strength Urinary Pain Relief Caplet (phenazopyridine hydrochloride) tablets is • Adults and children 12 years and over: Take 2 tablets 3 times daily with or after meals as needed for up to two days. This formulation utilizes a tablet, film coated delivery system. Marketed by Strive Pharmaceuticals Inc., this product is identified by NDC 70692-178.
Identification & Billing
- RxCUI: 1094147 - phenazopyridine HCl 99.5 MG Oral Tablet
- RxCUI: 1094147 - phenazopyridine hydrochloride 99.5 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70692 - Strive Pharmaceuticals Inc.
- 70692-178 - Good Remedies Maximum Strength Urinary Pain Relief Caplet
- 70692-178-08 - 1 BLISTER PACK in 1 CARTON / 8 TABLET, FILM COATED in 1 BLISTER PACK
- 70692-178 - Good Remedies Maximum Strength Urinary Pain Relief Caplet
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70692-178-08 identifies a specific commercial package of 1 blister pack in 1 carton / 8 tablet, film coated in 1 blister pack of Good Remedies Maximum Strength Urinary Pain Relief Caplet, a human over the counter drug labeled by Strive Pharmaceuticals Inc.. This tablet, film coated is formulated for oral use and contains phenazopyridine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Strive Pharmaceuticals Inc. on January 06, 2025. The current certification is valid through December 31, 2026.
How is this Strive Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70692017808. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.